24 ^Correspondence to: A.R aregev@broadinstitute.com and R.A.F richard.flavell@yale.edu 25 Psoriasis pathology is driven by the type 3 cytokines IL-17 and Il-22, but little is understood 26 about the dynamics that initiate alterations in tissue homeostasis. Here, we use mouse 27 models, single-cell RNA-seq (scRNA-seq), computational inference and cell lineage mapping 28 to show that psoriasis induction reconfigures the functionality of skin-resident ILCs to 29 initiate disease. Tissue-resident ILCs amplified an initial IL-23 trigger and were sufficient, 30 without circulatory ILCs, to drive pathology, indicating that ILC tissue remodeling initiates 31 psoriasis. Skin ILCs expressed type 2 cytokines IL-5 and IL-13 in steady state, but were 32 epigenetically poised to become ILC3-like cells. ScRNA-seq profiles of ILCs from psoriatic 33 and naïve skin of wild type (WT) and Rag1 -/mice form a dense continuum, consistent with 34 this model of fluid ILC states. We inferred biological "topics" underlying these states and 35 their relative importance in each cell with a generative model of latent Dirichlet allocation, 36 showing that ILCs from untreated skin span a spectrum of states, including a 37 naïve/quiescent-like state and one expressing the Cd74 and Il13 but little Il5. Upon disease 38 induction, this spectrum shifts, giving rise to a greater proportion of classical Il5-and Il13-39 expressing "ILC2s" and a new, mixed ILC2/ILC3-like subset, expressing Il13, Il17, and Il22. 40
unchecked, drive pathological remodeling. 48
INTRODUCTION 49
Psoriasis pathology is driven by the type 3 cytokines IL-17 and Il-22 (Nograles, Zaba et al. 2008, 50 Cai, Shen et al. 2011). The dermal inflammation and acanthosis induced by IL-23 are thought to 51 be mediated by the Th17-cell associated cytokine IL-22. While both IL-17 and IL-22 are produced 52 at elevated levels in psoriatic skin, the major cell source of these cytokines during disease remains 53 unclear. In psoriasis patients, γδ T cells were found to be greatly increased in affected skin and 54 produced large amounts of IL-17, suggesting they may play a key role in pathogenesis (Cai, Shen 55 et al. 2011) . Recently, however, IL-17 and IL-22 producing ILC3s have been proposed to be a 56 significant source of cytokine production during psoriasis (Teunissen, Munneke et al. 2014 , 57 Villanova, Flutter et al. 2014 ). These cells are thought to be activated in response to IL-1β and IL-58 23, whose levels correlate with disease severity, and are decreased following antitumor necrosis 59 factor-α (anti-TNFα) treatment. The presence of a novel ILC population in psoriatic skin that 60 responds to one of the most effective biologic therapeutics suggests that dysregulation of ILCs is 61 a contributing factor to psoriasis pathogenesis. While ILC3s dominate psoriatic skin (Pantelyushin, 62 Haak et al. 2012), in healthy individuals the majority of ILCs are represented by group 2 ILCs, 63 defined by IL-5 and IL-13 production (Roediger, Kyle et al. 2013 , Spencer, Wilhelm et al. 2014 . 64
We wanted to determine at what point during disease progression the frequency of ILC2s and 65
ILC3s shifts and whether a potential for conversion between these cell types underlies this disease. 66 67 High parallel single-cell RNA sequencing (scRNA-seq) has become a powerful tool for unbiased 68 analysis of various cells types. Analyses of immune cell classes, such as ILCs, typically treat them 69 as collections of discrete immune cell "types", yet these cell types may share important biological 70 signals and have been observed in some contexts to essentially continuously span a functional 71 spectrum. To capture and explore fluid, mixed transcriptional states, we used latent Dirichlet 72 allocation (LDA), or "topic modeling", a statistical data mining approach for discovering the 73 abstract topics that explain the words occurring in a collection of text documents (Blei 2003) . 74
Applied to scRNA-Seq, each "document" corresponds to a cell, and a "topic" corresponds to a 75 biological program, modeled as a distribution over expressed genes, rather than words. Given the 76 number of topics as a parameter, both topics and the mixture weights in cells are inferred without 77 supervision. LDA was independently introduced in population genetics to model admixed 78 individuals with ancestry from multiple populations (Pritchard, Stephens et al. 2000) . In genomics, 79 it has been applied to deconvolute cell types in population RNA-seq ( To determine which cells are key to initiate psoriatic disease, we studied a subcutaneous IL-23 87 injection model, which leads to increased skin thickness after five days of daily injections ( Fig.  88   1A, Fig. S1A ). First, we assessed the role of different immune cell types in this model (Fig. 1B,  89 Fig. S1B and C). Consistent with previous results, the Rag2 -/-Il2rg -/double mutant, which lacks 90 all lymphocytes, did not show any increase in ear thickness, whereas Rag1 -/mice, which have 91 intact ILCs, showed significant increase in skin thickness over the treatment course. This is also 92 consistent with an increased number of human ILC3s recently observed in psoriatic patients 93 2012), analyzing Tcrd -/mice, which lack only gd T cells, we found no evidence that they contribute 96 to disease initiation ( Fig. 1B) . Next, to further confirm the role of ILCs in disease initiation, we 97 adoptively transferred sorted skin ILCs from untreated WT mice into Rag2 -/-Il2rg -/mice, and 98 observed significant skin thickening in treated versus untreated recipient mice (Fig. 1C) . Finally, 99
we assessed the contributions of circulatory versus tissue-resident lymphocytes in the psoriasis 2018). We compared disease phenotype between control mice and those treated with FTY720, 104 which blocks signaling from the S1P1 receptor, preventing egress of T cells from secondary 105 lymphoid tissues and limit trafficking of induced ILC2s (Matloubian, Lo et al. 2004 , Huang, Mao 106 et al. 2018 ). FTY720-treated mice had the expected reduction of circulating total white blood cells, 107 but showed no difference in psoriasis phenotype induction upon IL-23 administration compared 108 with untreated controls, in both WT or Rag1 -/-(lacking T and B cells) mice ( Fig. 1C and E) . Thus, 109 in contrast to a model of lung inflammation (Huang, Mao et al. 2018) , in psoriasis, tissue-resident 110
ILCs are sufficient to drive disease pathology and are critical for amplifying the response to IL-111
112 113
We observed that skin ILCs expressed the type 2 cytokines IL-5 and IL-13 in steady state, but 114 showed potential to plastically to assume ILC3-like states. Consistent with prior reports that naïve 115 mouse skin ILCs are comprised almost exclusively of GATA3 + ILC2s (Roediger, Kyle et al. 2013) , 116 total ILCs isolated from healthy mouse skin and treated with the type 2 alarmin cytokines IL-25 117 and L-33 had a strong type 2 activation, as indicated by expression of Areg and Il13 (Fig. S1D) . 118
However, total ILCs treated with IL-23 and IL-1b instead strongly expressed Il22 and Il17a (Fig.  119   S1D) , suggesting that tissue-resident skin ILCs may have potential for type 2-3 plasticity. Such 120 plasticity has been previously reported in IL-17A co-expressing "inflammatory ILC2s" in the lung 121 levels within 10 days after the initial IL-23 injection ( Fig. 1F) , this initial challenge promoted a 126 stronger type 3 response upon re-challenge. Specifically, mice showed a significantly more severe 127 phenotype after a second series of IL-23 injections, compared to their initial response ( Fig. 1F and 128 ILC population with unexpected potential for differentiation, rather than by recruiting circulating 141
ILCs to replace a homogenous, terminally differentiated skin-resident ILC2 population. 142
143
To assess the molecular heterogeneity of skin-resident ILCs and its functional implications for the 144 IL-23 response, we collected massively parallel scRNA-seq profiles from sorted pure total ILCs 145 from WT and Rag1 -/mice from naïve and IL-23 induced conditions, predominantly uncovering a 146 large heterogeneous population of cells ( Fig. 1I) . Specifically, clustering on principle components, 147 followed by differential expression analysis (Methods), identified a few discrete subsets of cells, 148
including a Rag1 -/--specific subset (A), a cluster of proliferating cells from all conditions and 149 genotypes (B), and a cluster specific to the induced condition with very high Il22 expression and 150 some Il13 expression (C) ( Fig. 1J, Fig. S1H ). However, the vast majority of cells (81%) formed a 151 single, large heterogeneous and continuous "cloud" (D), which was not simply driven by technical 152 factors (Methods), with multiple sub-regions enriched for specific functional programs, including 153 type 2 immune response ( Fig. 1J) . Importantly, no single partitioning conformed to the expression 154
of key genes and processes, and moreover, some biological processes were unexpectedly shared 155 across subsets of the cells from distinct clusters ( Fig. 1J) . This highlighted the diversity of potential 156 cell states, and the need to capture them by more nuanced computational analysis. 157
158
To characterize the heterogeneity of ILCs during IL-23 response, we created a generative topic 159 model based on LDA. Analogous to a text document, a cell is modeled as a mixture of a small 160 number of topics, where the mixture weights indicate the relative prominence of the corresponding 161 biological process in that cell. Multiple topics may include the same gene, reflecting the gene's 162 roles in different processes. Topic modeling permits a cell to have multiple, non-hierarchical 163 "identities" that potentially differ in importance, a feature particularly relevant for analyzing 164 cellular plasticity ( Fig. 2A) . Indeed, we observed complex patterns of topic sharing across clusters, 165
suggesting that topic weights capture relationships not well described by clusters and, through their 166 functional interpretation, enable a more nuanced view of similarities and differences among cells 167 ( Fig. 2B) . Several choices for the number of topics may result in valid models, though too large a 168 number of topics can result in overfitting and low interpretability. We found that in this dataset, 169 15 topics captured important changes during disease induction, as well as other signals, without 170 obvious signs of overfitting ( Fig. S2A, Methods) . 171
172
Our topics spanned three categories: (1) highly ribosomal-or mitochondrial-dominated (e.g., 173
Topic 1, 6), possibly reflecting technical quality or cell size, (2) cluster-specific topics (e.g., Topic 174 7, 14, 15), and (3) "sub-regional" topics, that is, those featured in sub-regions of the "cloud", also 175 often simultaneously present in sub-regions of other clusters (e.g., Topics 2, 4, 8, 11, 13) ( Fig. 2C  176 and D, Fig. S2B-D) . "Cell quality" topics can help distinguish the influence of technical 177 confounders better than simple thresholds, but also may reflect a cell's level of biological 178 activation (Wallrapp, Riesenfeld et al. 2017) . "Cluster-specific topics" are analogous to results 179 from standard differential expression analysis. For example, cluster C is unique in having large 180 weights for Topic 15, which is characterized by expression of ILC3-associated genes Il22, Il17a, 181
and Il17f, as well as the cytotoxic gene Gzmb and the type 2 genes Ly6a (Sca-1) and Il13 ( Fig. 2C  182 and D, Fig. S2B and C). As another example, Topic 7 is uniquely highly weighted in cells from 183 the Rag1 -/--specific cluster A, and features the NK-associated genes Klrd1 and Tyrobp and the 184 immunoglobulin E receptor Fcer1g, indicating that Rag1 -/mice might have an overrepresentation 185 of skin-resident ILC1s (Fig. 1J, Fig. S2D ). 186
187
The "sub-regional" topics highlighted functional states that are prominent within the "cloud" and 188 Fig. 2C and D) . 207
Topic 13, highlighting a substantial sub-region of both the "cloud" and induced-specific cluster C, 208 is more specific to WT disease induction, uniquely expresses Il5, and also includes other type 2 209 genes, such as Cxcl2, Il1rl1 (ST-2), Il13, and Ly6a (Sca-1), the latter of which featured in all 210 induced topics ( Fig. 2C and D, Fig. S2B and C) . The presence of some cells with high weights 211
for both Topics 13 and 15 indicates that an activated type 2 response apparently co-exists with the 212 anticipated type 3 response. Finally, Topic 4, which is largely mutually exclusive with Topic 13 213 across cells, includes genes involved in actin remodeling, a process previously shown to be 214 important during T-cell activation (Kumari, Curado et al. 2014) ( Fig. 2C and D) . 215
216
We hypothesized that cells can transition between some of these programs or states, as such 217 transitions would be consistent with the dense transcriptional continuum observed. Unlike modeling does not assume the existence of an "axis" of progression, which may not exist in settings 220 such as the untreated condition. Moreover, when a trajectory does exist, it may be reflected only 221 in specific aspects of the transcriptional profiles. Indeed, a temporal "induction" dimension in our 222 data was revealed most clearly when we focused on specific topics related to immune repression 223 or activation. To identify transitional relationships in the context of the biological processes 224 reflected by these topics, we created a diffusion map only from those cells highly weighted for 225 Topics 2,4,8,11,13, and 15, but not for Topics 6 or 7, and used only the most distinguishing genes 226 for each topic as input ( Fig. S3A-C, Methods) . 227
228
The diffusion map (Fig. 3A, Fig. S3D ) proposes several parallel state transitions that cells undergo 229 in the tissue, in particular highlighting a quiescence-ILC2-ILC3s state trajectory in the disease. 230
First, cells from the naïve condition lie in a triangular region in the plane spanned by diffusion 231 components (DC) 2 and 3 with corners up-weighted for Topic 2 ("resting"), 8 ("naïve-quiescent"), 232 and 11 ("antigen presentation"), respectively ( Fig. 3A and B .i-iii). Their distribution throughout 233 the triangle suggests that in the untreated condition, cells range over all mixtures of these states. 234
Second, DC1 captures the induced response shared in both WT and Rag1 -/mice ( Fig. 3A, Fig.  235 S3D), such that as their DC1 coordinate ("induction") increases, cells typically have relatively 236 lower weights for Topics 2, 8, and 11 ( Fig. 3B.i-iii, Fig. S3E .i-iii), and higher weights for Topic 237 15 ("Il22/Il117"), Topic 4 ("actin remodeling"), and, specifically for cells from WT mice, Topic 238 13 ("Il5/Cxcl2") ( Fig. 3B.iv-vi, Fig. S3E .iv-vi). Genotype-specific differences in the induction 239 response are further captured by DC4, such that cells from WT and Rag1 -/mice have increasingly 240 different DC4 coordinates as DC1 coordinate increases ( Fig. S3D) . 241
242
A focused diffusion map model ( Fig. 3C ) generated only from cells up-weighted for Topic 8, 13, 243 or 15 (Methods), shows continuous expression changes from Topic 8 to 13 to 15, as DC 1 (in this 244 map) coordinate increases ( Fig. 3D and E) . Indeed, DC1 is particularly well correlated with 245 expression of the gene Srgn, a proteoglycan that is critical for the trafficking and storage of Gzmb 246 IL-23 challenge further elevated the number of ex-IL-5 cells producing IL-22 and IL-17A ( Fig.  267   4C and D) . Moreover, cells that expressed ILC3 type cytokines no longer expressed IL-5 ( Fig.  268   4D) . Our results show the in vivo potential for plasticity among skin ILCs and demonstrates that 269 some cells expressing ILC3 type cytokines expressed IL-5 at one stage of their lifetime. Finally, 270
we also tested our model's prediction that there is a subset of skin ILCs in the psoriasis model that 271 co-expresses the type 2 cytokine IL-13 with both of the type 3 cytokines IL-22 and IL-17A. Indeed, 272 intracellular measurements of these three cytokines showed that, consistent with the predictions, 273 nearly 20% in Rag1 -/and 10% in WT and Tcrd -/of cells expressing IL-22 and IL-17A also co-274 express IL-13 ( Fig. 4E and F) . Experimentally combining scRNA-seq, ATAC-seq, and in vivo fate mapping in the psoriasis 280 mouse model with new analytical approaches, we showed the presence of previously undescribed 281 naïve/quiescent-like tissue-resident ILCs and the ability of activated ILC2s to differentiate to 282 pathological ILC3s. We further discovered a novel subset of ILCs expressing IL-13 and IL-22/IL-283
17A in response to IL-23 stimulation. Our work highlights the limitation of experimental and 284 computational analyses of immune cells that treat them as discrete immune "types", when immune 285 cells may share biological signals and span continuous spectra. In our system, we did not observe 286 any discrete boundaries in single-cell expression profiles that neatly partitioned naïve/quiescent-287 like ILCs from activated type 2 cells, or type 2 cells from type 3 cells. Rather, the entire population 288 of skin-resident ILCs was functionally reconfigured and its spectrum shifted by disease induction. and IL-22 BFP generated in our laboratory. In order to maximize the Cre recombination and increase 317 the signal of Rosa26 YFP positive cells, we used homozygous IL-5 dTomato,Cre . We observed little to 318 no difference in IL-23 induced skin thicknening (Fig. S4A) . was injected daily into the ear skin of anesthetized mice in 4 consecutive days. As a control 20µl 333 of PBS was used with the same injection intervals. For the second challenge experiment, we waited 334 10 days, monitoring the skin thickness before repeating 4-day injection regimen. Skin thickness 335 was measured daily with calipers. When indicated, FTY720 (1mg/kg) was dissolved in PBS and 336 administered i.p on day -1, 1 and 3 of the experiment. Skin tissue was collected on day 5 for 337 histology imaging, flow cytometry analysis or cell sorting. Click's medium with 10 ng ml -1 IL-2 (R&D Systems) and 25 ng ml -1 IL-25 (R&D Systems) with 362 10 ng ml -1 , IL-33 (R&D Systems) or IL-23 25 ng ml -1 (Provided by Abbvie) with TGFb 10 ng ml -363 1 (R&D Systems) and IL-1b 10 ng ml -1 (R&D Systems). Cells were collected for RNA extraction 364 and qRT-PCR after 5 days of culture in 37°C and 5%CO2. were outliers in their sample of origin in terms of number of genes or number of unique molecular 410 identifiers (UMIs), which eliminated 5.8-7.9% of cells per sample (Fig. S4B) , or outliers across 411 all samples in percentage of mitochondrial genes, which eliminated at most 0.5% of remaining 412 cells (Fig. S4C) . Sample-specific cut-offs ranged from 575-2,400 genes per cell for the Rag1 -/-413 untreated sample to 850-3,100 genes per cell for the WT induced sample. 414 415 Normalization. To normalize gene counts, we used a scaling factor that reflected the expected 416 number of UMIs in each sample (Fig. S4D) , rather than scaling all cells to a constant size, as in Taking the log of scaled UMI counts gives the normalized expression values referred to as logTPX. 421 422 Determination of variable genes. We fit the count data to a null model based on a negative 423 binomial distribution that explains the expected technical variation for each gene, given its 424 expression level, as previously described (Pandey, Shekhar et al. 2018) . A gene was considered to 425 exhibit non-technical variability if it had mean counts above 0.005 and a coefficient of variation 426 at least log(0.5) times that predicted by the null model (Fig. S4E) . We performed variable gene 427 selection separately for each sample as well as for pooled samples from WT mice and, separately, 428
from Rag1 -/mice. To reduce downstream technical effects of the variation in extremely highly 429 expressing genes, we then removed any genes that had mean counts above 4 in WT or, separately, 430
Rag1 -/cells (these were mostly ribosomal protein genes). The resulting conservative set of 271 431 genes was then used for the singular value decomposition (SVD). We chose this approach to ensure 432 that noisy variable gene selection was not a cause of the heterogeneity in the "cloud". Note that 433 downstream results were qualitatively similar and robust to several parameter settings, which yield 434 variable gene sets of very different sizes, as well as to other selection approaches (including the 435 proportion of variance explained with larger components, we selected the top 18 eigenvectors for 441 subsequent analysis, and confirmed that the resulting analyses were not sensitive to this exact 442 choice. We used these components with Seurat's FindClusters() and RunTSNE() functions, with 443 other parameter settings set to default, to cluster the cells, and to separately create a t-stochastic 444 neighborhood embedding (tSNE) for visualization, respectively. As previously described, 445
FindClusters() optimizes a modularity function on a k-nearest-neighbor graph computed from the 446 top eigenvectors. 447
Removal of non-ILC clusters. Based on expression of marker genes across clusters, we 449
determined that a few very distinct clusters were unlikely to be ILCs: cells in those clusters had 450 little expression of Ptprc (CD45), and high expression of Col1a2, or Tie1 and Pecam1, or Krt15. 451
Cells from these non-ILC clusters were removed, and the steps of normalizing the data, selecting 452 variable genes, performing PCA, and creating a tSNE were repeated as before, but the top 20 453 components of the SVD were used for subsequent analysis. After these steps, 18,852 cell profiles 454 approach to fitting the model (Taddy 2012) . Some approaches to selecting an appropriate value of 461 K rely on having labeled training data for the model. Since we do not have such a model, we fit 462 the model for a range of values and computed the Akaike and Bayesian information criteria (AIC 463 and BIC) using the estimated likelihood returned by FitGoM() ( Fig. S2A) . Since AIC and BIC risk 464 under-and over-penalizing the fit, respectively, we selected a value of K at a point where the AIC 465 curve had begun to decrease less steeply and the BIC curve had begun to climb. 466 467 Diffusion maps. To select cells and genes for the construction of diffusion maps, a cell was 468 considered "highly weighted" for a topic if its weight for the topic was above a topic-specific 469 threshold capturing the upper tail of the distribution (Fig. S3A and B) . The analysis is not sensitive 470 to the exact choice of threshold. Cells were used in the large diffusion map (Fig. 3A) if they were 471 highly weighted for any of topics 2, 4, 8, 11, 13, or 15, but not 6 or 7 ( Fig. S3B and C) . A gene 472 was considered to be in the "top n genes" for a topic if it was returned by the CountClust function 473
ExtractTopFeatures(), which selects genes that are most critical for separating one topic from the 474 others (similar to differential expression analysis between clusters), with the following parameter 475 settings: top_features=n, method="poisson", options="min", shared=TRUE. For visualization, the 476 "Score" shown for top genes (Fig. 2C, Fig. S2D ) was computed as 100*x, where x is the Kullback-477
Leibler divergence score output by ExtractTopFeatures(), and then plotted on a logarithmic scale. 478
Genes were included in the large diffusion map if they were in the top 50 genes for topics 2, 4, 8, 479 11, 13, or 15, but not in the top 5 genes for any other topics. For the smaller diffusion map ( Fig.  480   3C) , cells and genes were selected in an analogous way, but only for the three topics 8, 13, and 15. 481
Overall, the larger diffusion map was computed on 7,888 cells and 245 genes, and the smaller one 482 on 3,785 cells and 130 genes. To build the diffusion map, we gave the expression data for these 483 cells and genes as input to the DiffusionMap() function from the destiny R package (Angerer, Fig. 1J (B, left) , or by expression (color bar, logTPX (Methods)) of Cd83, a Topic-11 associated gene (b, right). of topic weights q*,j (x axis) for cells grouped by treatment or genotype (as in Fig. 2c ).
Analogous plots for

